[The Immunosuppressive Function of Myeloid-derived Suppressor Cells Is Regulated by the HMGB1-TLR4 Axis]
- PMID: 29386427
- DOI: 10.1248/yakushi.17-00158
[The Immunosuppressive Function of Myeloid-derived Suppressor Cells Is Regulated by the HMGB1-TLR4 Axis]
Abstract
Myeloid-derived suppressor cells (MDSCs) accumulate under pathological conditions, including cancer and chronic inflammation, and they suppress various immune responses such as T cell proliferation. Although several inflammatory signals enhance the differentiation and/or function of MDSCs, it is not clear which factors regulate their differentiation and immunosuppressive function. It has been highlighted that damage-associated molecular patterns (DAMPs) play important roles in the induction of inflammation. One of the DAMPs, the high mobility group box 1 (HMGB1), is released from necrotic cells and secreted by macrophages. It has been shown that HMGB1 level is elevated in tumors and tumor-bearing hosts. It has also been reported that HMGB1 transduces intracellular signaling via several receptors, including the receptor for advanced glycation end-products (RAGE) and the toll-like receptor (TLR)4, both of which enhance the differentiation and/or function of MDSCs. However, the effects of HMGB1 on MDSCs remain unclear. In the present study, we examined the effect of HMGB1 on in vitro MDSC differentiation and immunosuppressive functions. Since murine bone marrow (BM) cells can differentiate into MDSCs upon granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulation for 4 d in vitro, we cultured murine BM cells in the presence of HMGB1 and GM-CSF. The results demonstrated that HMGB1 enhanced the suppressive activity of in vitro MDSCs, depending on TLR4, whereas lipopolysaccharide (LPS), one of the TLR4 ligands, interfered with this differentiation and immunosuppressive activity of in vitro MDSCs, depending on TLR4. Our findings thus suggest that the HMGB1-TLR4 axis enhances the immunosuppressive function of MDSCs.
Keywords: high mobility group box 1; myeloid-derived suppressor cell; toll-like receptor 4.
Similar articles
-
[Recombinant HMGB1 induces the differentiation of mouse myeloid cells into myeloid-derived suppressor cells in vitro].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Oct;32(10):1362-1365. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016. PMID: 27667463 Chinese.
-
S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling.J Immunother Cancer. 2024 Sep 11;12(9):e009552. doi: 10.1136/jitc-2024-009552. J Immunother Cancer. 2024. PMID: 39266214 Free PMC article.
-
High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.Am J Pathol. 2012 Jul;181(1):98-110. doi: 10.1016/j.ajpath.2012.03.039. Epub 2012 May 22. Am J Pathol. 2012. PMID: 22634181
-
Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).Angiogenesis. 2008;11(1):91-9. doi: 10.1007/s10456-008-9093-5. Epub 2008 Feb 9. Angiogenesis. 2008. PMID: 18264787 Review.
-
Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment.Biomark Res. 2020 Jun 16;8:21. doi: 10.1186/s40364-020-00201-8. eCollection 2020. Biomark Res. 2020. PMID: 32551121 Free PMC article. Review.
Cited by
-
Unboxing the molecular modalities of mutagens in cancer.Environ Sci Pollut Res Int. 2022 Sep;29(41):62111-62159. doi: 10.1007/s11356-021-16726-w. Epub 2021 Oct 5. Environ Sci Pollut Res Int. 2022. PMID: 34611806 Free PMC article. Review.
-
Targeting myeloid-derived suppressor cells for cancer therapy.Cancer Biol Med. 2021 Aug 17;18(4):992-1009. doi: 10.20892/j.issn.2095-3941.2020.0806. Cancer Biol Med. 2021. PMID: 34403220 Free PMC article. Review.
-
Protective role of curcumin in disease progression from non-alcoholic fatty liver disease to hepatocellular carcinoma: a meta-analysis.Front Pharmacol. 2024 Jan 19;15:1343193. doi: 10.3389/fphar.2024.1343193. eCollection 2024. Front Pharmacol. 2024. PMID: 38313314 Free PMC article.
-
Dual roles of myeloid-derived suppressor cells induced by Toll-like receptor signaling in cancer.Oncol Lett. 2021 Feb;21(2):149. doi: 10.3892/ol.2020.12410. Epub 2020 Dec 24. Oncol Lett. 2021. PMID: 33552267 Free PMC article. Review.
-
Curcumin inhibits the growth of liver cancer by impairing myeloid-derived suppressor cells in murine tumor tissues.Oncol Lett. 2021 Apr;21(4):286. doi: 10.3892/ol.2021.12547. Epub 2021 Feb 12. Oncol Lett. 2021. PMID: 33732362 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources